Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Growth 2022-2028

  • LP 4775857
  • 129 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) will have significant change from previous year. According to our (LP Information) latest study, the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market, reaching US$ million by the year 2028. As for the Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Tetrahydrocannabinol (THC) and Cannabidiol (CBD) players cover Kazmira, CW Hemp/CW Botanicals, Freedom Leaf, and Green Road, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Tetrahydrocannabinol (THC)

Cannabidiol (CBD)

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Pharmaceuticals Industry

Food Industry

Cosmetics Industry

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Kazmira

CW Hemp/CW Botanicals

Freedom Leaf

Green Road

Medical Marijuana

Folium Biosciences

HempLife Today

Cannavest

Pharmahemp

ENDOCA

CBD American Shaman

NuLeaf Naturals

Select Oil

K.I.N.D. Concentrates

Canopy Growth Corporation

Aphria

Emblem Cannabis Oils

Whistler

The Lab

Absolute Terps

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Country/Region, 2017, 2022 & 2028

2.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Type

2.2.1 Tetrahydrocannabinol (THC)

2.2.2 Cannabidiol (CBD)

2.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type

2.3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2017-2022)

2.3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sale Price by Type (2017-2022)

2.4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Application

2.4.1 Pharmaceuticals Industry

2.4.2 Food Industry

2.4.3 Cosmetics Industry

2.4.4 Other

2.5 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application

2.5.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sale Market Share by Application (2017-2022)

2.5.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sale Price by Application (2017-2022)

3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Company

3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Breakdown Data by Company

3.1.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Sales by Company (2020-2022)

3.1.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Company (2020-2022)

3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Revenue by Company (2020-2022)

3.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Company (2020-2022)

3.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Company (2020-2022)

3.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sale Price by Company

3.4 Key Manufacturers Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Location Distribution

3.4.2 Players Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Geographic Region

4.1 World Historic Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Geographic Region (2017-2022)

4.1.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Revenue by Geographic Region

4.2 World Historic Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country/Region (2017-2022)

4.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Revenue by Country/Region

4.3 Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth

4.4 APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth

4.5 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth

4.6 Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth

5 Americas

5.1 Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country

5.1.1 Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2017-2022)

5.1.2 Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2017-2022)

5.2 Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type

5.3 Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region

6.1.1 APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2017-2022)

6.1.2 APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region (2017-2022)

6.2 APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type

6.3 APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Country

7.1.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2017-2022)

7.1.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2017-2022)

7.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type

7.3 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Country

8.1.1 Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2017-2022)

8.2 Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type

8.3 Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

10.3 Manufacturing Process Analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

10.4 Industry Chain Structure of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors

11.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customer

12 World Forecast Review for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Geographic Region

12.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Forecast by Region

12.1.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Forecast by Region (2023-2028)

12.1.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Forecast by Type

12.7 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Forecast by Application

13 Key Players Analysis

13.1 Kazmira

13.1.1 Kazmira Company Information

13.1.2 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.1.3 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Kazmira Main Business Overview

13.1.5 Kazmira Latest Developments

13.2 CW Hemp/CW Botanicals

13.2.1 CW Hemp/CW Botanicals Company Information

13.2.2 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.2.3 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CW Hemp/CW Botanicals Main Business Overview

13.2.5 CW Hemp/CW Botanicals Latest Developments

13.3 Freedom Leaf

13.3.1 Freedom Leaf Company Information

13.3.2 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.3.3 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Freedom Leaf Main Business Overview

13.3.5 Freedom Leaf Latest Developments

13.4 Green Road

13.4.1 Green Road Company Information

13.4.2 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.4.3 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Green Road Main Business Overview

13.4.5 Green Road Latest Developments

13.5 Medical Marijuana

13.5.1 Medical Marijuana Company Information

13.5.2 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.5.3 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Medical Marijuana Main Business Overview

13.5.5 Medical Marijuana Latest Developments

13.6 Folium Biosciences

13.6.1 Folium Biosciences Company Information

13.6.2 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.6.3 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Folium Biosciences Main Business Overview

13.6.5 Folium Biosciences Latest Developments

13.7 HempLife Today

13.7.1 HempLife Today Company Information

13.7.2 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.7.3 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 HempLife Today Main Business Overview

13.7.5 HempLife Today Latest Developments

13.8 Cannavest

13.8.1 Cannavest Company Information

13.8.2 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.8.3 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Cannavest Main Business Overview

13.8.5 Cannavest Latest Developments

13.9 Pharmahemp

13.9.1 Pharmahemp Company Information

13.9.2 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.9.3 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Pharmahemp Main Business Overview

13.9.5 Pharmahemp Latest Developments

13.10 ENDOCA

13.10.1 ENDOCA Company Information

13.10.2 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.10.3 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 ENDOCA Main Business Overview

13.10.5 ENDOCA Latest Developments

13.11 CBD American Shaman

13.11.1 CBD American Shaman Company Information

13.11.2 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.11.3 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 CBD American Shaman Main Business Overview

13.11.5 CBD American Shaman Latest Developments

13.12 NuLeaf Naturals

13.12.1 NuLeaf Naturals Company Information

13.12.2 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.12.3 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 NuLeaf Naturals Main Business Overview

13.12.5 NuLeaf Naturals Latest Developments

13.13 Select Oil

13.13.1 Select Oil Company Information

13.13.2 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.13.3 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Select Oil Main Business Overview

13.13.5 Select Oil Latest Developments

13.14 K.I.N.D. Concentrates

13.14.1 K.I.N.D. Concentrates Company Information

13.14.2 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.14.3 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 K.I.N.D. Concentrates Main Business Overview

13.14.5 K.I.N.D. Concentrates Latest Developments

13.15 Canopy Growth Corporation

13.15.1 Canopy Growth Corporation Company Information

13.15.2 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.15.3 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Canopy Growth Corporation Main Business Overview

13.15.5 Canopy Growth Corporation Latest Developments

13.16 Aphria

13.16.1 Aphria Company Information

13.16.2 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.16.3 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Aphria Main Business Overview

13.16.5 Aphria Latest Developments

13.17 Emblem Cannabis Oils

13.17.1 Emblem Cannabis Oils Company Information

13.17.2 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.17.3 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Emblem Cannabis Oils Main Business Overview

13.17.5 Emblem Cannabis Oils Latest Developments

13.18 Whistler

13.18.1 Whistler Company Information

13.18.2 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.18.3 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Whistler Main Business Overview

13.18.5 Whistler Latest Developments

13.19 The Lab

13.19.1 The Lab Company Information

13.19.2 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.19.3 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 The Lab Main Business Overview

13.19.5 The Lab Latest Developments

13.20 Absolute Terps

13.20.1 Absolute Terps Company Information

13.20.2 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

13.20.3 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Absolute Terps Main Business Overview

13.20.5 Absolute Terps Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Tetrahydrocannabinol (THC)

Table 4. Major Players of Cannabidiol (CBD)

Table 5. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2017-2022) & (MT)

Table 6. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2017-2022)

Table 7. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2017-2022) & ($ million)

Table 8. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2017-2022)

Table 9. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sale Price by Type (2017-2022) & (US$/kg)

Table 10. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2017-2022) & (MT)

Table 11. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2017-2022)

Table 12. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2017-2022)

Table 13. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application (2017-2022)

Table 14. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sale Price by Application (2017-2022) & (US$/kg)

Table 15. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Company (2020-2022) & (MT)

Table 16. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Company (2020-2022)

Table 17. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Company (2020-2022)

Table 19. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sale Price by Company (2020-2022) & (US$/kg)

Table 20. Key Manufacturers Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Producing Area Distribution and Sales Area

Table 21. Players Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Products Offered

Table 22. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Geographic Region (2017-2022) & (MT)

Table 26. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share Geographic Region (2017-2022)

Table 27. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country/Region (2017-2022) & (MT)

Table 30. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country/Region (2017-2022)

Table 31. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2017-2022) & (MT)

Table 34. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2017-2022)

Table 35. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country (2017-2022)

Table 37. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2017-2022) & (MT)

Table 38. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2017-2022)

Table 39. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2017-2022) & (MT)

Table 40. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2017-2022)

Table 41. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2017-2022) & (MT)

Table 42. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region (2017-2022)

Table 43. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Region (2017-2022)

Table 45. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2017-2022) & (MT)

Table 46. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2017-2022)

Table 47. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2017-2022) & (MT)

Table 48. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2017-2022)

Table 49. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2017-2022) & (MT)

Table 50. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2017-2022)

Table 51. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country (2017-2022)

Table 53. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2017-2022) & (MT)

Table 54. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2017-2022)

Table 55. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2017-2022) & (MT)

Table 56. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2017-2022) & (MT)

Table 58. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2017-2022) & (MT)

Table 62. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2017-2022) & (MT)

Table 64. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

Table 66. Key Market Challenges & Risks of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

Table 67. Key Industry Trends of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

Table 68. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors List

Table 71. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customer List

Table 72. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Region (2023-2028) & (MT)

Table 73. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Forecast by Region

Table 74. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2023-2028) & (MT)

Table 77. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Region (2023-2028) & (MT)

Table 79. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2023-2028) & (MT)

Table 81. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2023-2028) & (MT)

Table 83. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Type (2023-2028) & (MT)

Table 85. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Application (2023-2028) & (MT)

Table 89. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share Forecast by Application (2023-2028)

Table 92. Kazmira Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 93. Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 94. Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 95. Kazmira Main Business

Table 96. Kazmira Latest Developments

Table 97. CW Hemp/CW Botanicals Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 98. CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 99. CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 100. CW Hemp/CW Botanicals Main Business

Table 101. CW Hemp/CW Botanicals Latest Developments

Table 102. Freedom Leaf Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 103. Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 104. Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 105. Freedom Leaf Main Business

Table 106. Freedom Leaf Latest Developments

Table 107. Green Road Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 108. Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 109. Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 110. Green Road Main Business

Table 111. Green Road Latest Developments

Table 112. Medical Marijuana Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 113. Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 114. Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 115. Medical Marijuana Main Business

Table 116. Medical Marijuana Latest Developments

Table 117. Folium Biosciences Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 118. Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 119. Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 120. Folium Biosciences Main Business

Table 121. Folium Biosciences Latest Developments

Table 122. HempLife Today Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 123. HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 124. HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 125. HempLife Today Main Business

Table 126. HempLife Today Latest Developments

Table 127. Cannavest Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 128. Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 129. Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 130. Cannavest Main Business

Table 131. Cannavest Latest Developments

Table 132. Pharmahemp Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 133. Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 134. Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 135. Pharmahemp Main Business

Table 136. Pharmahemp Latest Developments

Table 137. ENDOCA Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 138. ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 139. ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 140. ENDOCA Main Business

Table 141. ENDOCA Latest Developments

Table 142. CBD American Shaman Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 143. CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 144. CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 145. CBD American Shaman Main Business

Table 146. CBD American Shaman Latest Developments

Table 147. NuLeaf Naturals Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 148. NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 149. NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 150. NuLeaf Naturals Main Business

Table 151. NuLeaf Naturals Latest Developments

Table 152. Select Oil Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 153. Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 154. Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 155. Select Oil Main Business

Table 156. Select Oil Latest Developments

Table 157. K.I.N.D. Concentrates Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 158. K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 159. K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 160. K.I.N.D. Concentrates Main Business

Table 161. K.I.N.D. Concentrates Latest Developments

Table 162. Canopy Growth Corporation Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 163. Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 164. Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 165. Canopy Growth Corporation Main Business

Table 166. Canopy Growth Corporation Latest Developments

Table 167. Aphria Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 168. Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 169. Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 170. Aphria Main Business

Table 171. Aphria Latest Developments

Table 172. Emblem Cannabis Oils Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 173. Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 174. Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 175. Emblem Cannabis Oils Main Business

Table 176. Emblem Cannabis Oils Latest Developments

Table 177. Whistler Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 178. Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 179. Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 180. Whistler Main Business

Table 181. Whistler Latest Developments

Table 182. The Lab Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 183. The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 184. The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 185. The Lab Main Business

Table 186. The Lab Latest Developments

Table 187. Absolute Terps Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors

Table 188. Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered

Table 189. Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)

Table 190. Absolute Terps Main Business

Table 191. Absolute Terps Latest Developments

List of Figures

Figure 1. Picture of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

Figure 2. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Tetrahydrocannabinol (THC)

Figure 10. Product Picture of Cannabidiol (CBD)

Figure 11. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type in 2021

Figure 12. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2017-2022)

Figure 13. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Consumed in Pharmaceuticals Industry

Figure 14. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market: Pharmaceuticals Industry (2017-2022) & (MT)

Figure 15. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Consumed in Food Industry

Figure 16. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market: Food Industry (2017-2022) & (MT)

Figure 17. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Consumed in Cosmetics Industry

Figure 18. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market: Cosmetics Industry (2017-2022) & (MT)

Figure 19. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Consumed in Other

Figure 20. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market: Other (2017-2022) & (MT)

Figure 21. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2017-2022)

Figure 22. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application in 2021

Figure 23. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Company in 2021

Figure 25. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Geographic Region in 2021

Figure 27. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region (2017-2022)

Figure 28. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country/Region in 2021

Figure 29. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales 2017-2022 (MT)

Figure 30. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue 2017-2022 ($ Millions)

Figure 31. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales 2017-2022 (MT)

Figure 32. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue 2017-2022 ($ Millions)

Figure 33. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales 2017-2022 (MT)

Figure 34. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales 2017-2022 (MT)

Figure 36. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue 2017-2022 ($ Millions)

Figure 37. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country in 2021

Figure 38. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country in 2021

Figure 39. United States Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region in 2021

Figure 44. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Regions in 2021

Figure 45. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country in 2021

Figure 52. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country in 2021

Figure 53. Germany Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country in 2021

Figure 60. Egypt Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) in 2021

Figure 66. Manufacturing Process Analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

Figure 67. Industry Chain Structure of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390